Crohn's Disease

Real-World Analysis Show Takeda's Alofisel Clinical Remission Rate At Six-Months

AbbVie's Upadacitinib Hits Primary Goal In Induction Study In Patients With Crohn's Disease

How Crohn's Disease Opened My Eyes To The Healing Properties Of Cannabis

AbbVie's Upadacitinib Hits Primary Goal In Induction Study In Patients With Crohn's Disease

How Crohn's Disease Opened My Eyes To The Healing Properties Of Cannabis

Galapagos Assumes Responsibility Of Late-Stage Filgotinib Trial In Crohn's Disease

Analysts Slash Price Targets After Theravance's Failed Ulcerative Colitis Study

Galapagos Assumes Responsibility Of Late-Stage Filgotinib Trial In Crohn's Disease

Analysts Slash Price Targets After Theravance's Failed Ulcerative Colitis Study

Theravance Stock Plunges As JAK Inhibitor Flops Ulcerative Colitis Study

Cerecor's Crohn's Disease Candidate Shows Encouraging Response In Pretreated Patients

Crohn's Disease Recent News

Almost Half of Crohn's Disease Patients Achieved Endoscopic Response After One Year ff Maintenance Treatment with AbbVie's Risankizumab

AbbVie Inc (NYSE: ABBV) has announced positive top-line results from the Phase 3 maintenance study, FORTIFY, showing Skyrizi (risankizumab) achieved the co-primary endpoints of endoscopic response and clinical remission at one year in Crohn's disease.

Eli Lilly's Mirikizumab Improves Fatigue in Crohn's Disease Patients

JNJ's Stelara Fails to Beat AbbVie's Humira In Crohn's Disease Patients

Eli Lilly Abandons IL-23 Psoriasis Program, Instead Will Focus On Ulcerative Colitis, Crohn's Disease Indications

Takeda Files Japan Marketing Application For Darvadstrocel In Crohn's Disease

Alabama Senate Committee Passes Medical Cannabis Legalization Bill

Alabama looks to join the growing list of states legalizing medical marijuana. The Yellowhammer State’s Senate committee on Wednesday said yes to a medical marijuana legalization bill, moving it to the full floor for review, reports Marijuana Moment.

Video: How Can Cannabis Help Crohn's Disease?

This article was originally published on The Medical Cannabis Community, and appears here with permission.

Cannabis And Crohn's Disease

RedHill Earns Long-Awaited Boost On Positive Crohn's Data

Celgene May Have Lost Positive Sentiment, But Its Growth Thesis Hasn't Gone Anywhere

Pipeline Bomb: Analysts Review Celgene's Crohn's Diseases Failure

Exclusive: RedHill BioPharma CEO Talks Steering His Company Through A Year Heavy With Potential Catalysts

Protagonist Therapeutics Spikes Sharply After Agreement With Janssen

Celgene Shares Higher On Positive Crohn's Patient Data

AbbVie Says Risankizumab More Effective Than Placebo For Crohn's Disease Management

Pfizer Receives FDA Approval For Cheaper Version Of Johnson & Johnson's Top Drug Remicade